3 курс / Фармакология / Интеллектуальные_липидные_наноконтейнеры_в_адресной_доставке_лекарственных
.pdf229
451.Van der Woude I., Wagenaar A., Meekel A.A., ter Beest M.B., Ruiters M.H., Engberts J.B., Hoekstra D. (1997) Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery. Proc.Natl.Acad.Sci.U.S.A, 94, 1160-1165.
452.Obika S., Yu W., Shimoyama A., Uneda T., Miyashita K., Doi T., Imanishi T. (2001) Symmetrical cationic triglycerides: an efficient synthesis and application to gene transfer.
Bioorg.Med.Chem., 9, 245-254.
453.Loisel S., Floch V., Le Gall C., Ferec C. (2001) Factors influencing the efficiency of lipoplexes mediated gene transfer in lung after intravenous administration 1 *. J.Liposome Res., 11, 127-138.
454.Delepine P., Guillaume C., Floch V., Loisel S., Yaouanc J., Clement J., Des A.H., Ferec C. (2000) Cationic phosphonolipids as nonviral vectors: in vitro and in vivo applications. J.Pharm.Sci., 89, 629-638.
455.Koynova R., Wang L., MacDonald R.C. (2006) An intracellular lamellar-nonlamellar phase transition rationalizes the superior performance of some cationic lipid transfection agents. Proc.Natl.Acad.Sci.U.S.A, 103, 14373-14378.
456.Heyes J.A., Niculescu-Duvaz D., Cooper R.G., Springer C.J. (2002) Synthesis of novel cationic lipids: effect of structural modification on the efficiency of gene transfer.
J.Med.Chem., 45, 99-114.
457.Ferrari M.E., Rusalov D., Enas J., Wheeler C.J. (2002) Synergy between cationic lipid and co-lipid determines the macroscopic structure and transfection activity of lipoplexes.
Nucleic Acids Res., 30, 1808-1816.
458.Arpicco S., Canevari S., Ceruti M., Galmozzi E., Rocco F., Cattel L. (2004) Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids. Farmaco, 59, 869-878.
459.Ren T., Song Y.K., Zhang G., Liu D. (2000) Structural basis of DOTMA for its high intravenous transfection activity in mouse. Gene Ther., 7, 764-768.
460.Floch V., Loisel S., Guenin E., Herve A.C., Clement J.C., Yaouanc J.J., Des A.H., Ferec C. (2000) Cation substitution in cationic phosphonolipids: a new concept to improve transfection activity and decrease cellular toxicity. J.Med.Chem., 43, 4617-4628.
461.Ren T., Zhang G., Song Y.K., Liu D. (1999) Synthesis and characterization of aromatic ring-based cationic lipids for gene delivery in vitro and in vivo. J.Drug Target, 7, 285-292.
462.McGregor C., Perrin C., Monck M., Camilleri P., Kirby A.J. (2001) Rational approaches to the design of cationic gemini surfactants for gene delivery. J.Am.Chem.Soc., 123, 6215-6220.
463.Regelin A.E., Fankhaenel S., Gurtesch L., Prinz C., von Kiedrowski G., Massing U. (2000) Biophysical and lipofection studies of DOTAP analogs. Biochim.Biophys.Acta, 1464, 151-164.
464.Srilakshmi G.V., Sen J., Chaudhuri A., Ramadas Y., Rao N.M. (2002) Anchordependent lipofection with non-glycerol based cytofectins containing single 2-hydroxyethyl head groups. Biochim.Biophys.Acta, 1559, 87-95.
465.Kim H.S., Moon J., Kim K.S., Choi M.M., Lee J.E., Heo Y., Cho D.H., Jang D.O., Park Y.S. (2004) Gene-transferring efficiencies of novel diamino cationic lipids with varied hydrocarbon chains. Bioconjug.Chem., 15, 1095-1101.
466.Kim H.S., Song I.H., Kim J.C., Kim E.J., Jang D.O., Park Y.S. (2006) In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD (O,O'-dimyristyl-N- lysyl aspartate) and DMKE (O,O'-dimyristyl-N-lysyl glutamate). J.Control Release, 115, 234-
467.Koynova R., Wang L., Tarahovsky Y.S., MacDonald R.C. (2005) Lipid phase control of DNA delivery. Bioconjug.Chem., 16, 1335-1339.
468.Floch V., Le Bolc'h G., Audrezet M.P., Yaouanc J.J., Clement J.C., Des A.H., Mercier B., Abgrall J.F., Ferec C. (1997) Cationic phosphonolipids as non viral vectors for DNA transfection in hematopoietic cell lines and CD34+ cells. Blood Cells Mol.Dis., 23, 69-87.
469.Gaucheron J., Boulanger C., Santaella C., Sbirrazzuoli N., Boussif O., Vierling P. (2001) In vitro cationic lipid-mediated gene delivery with fluorinated glycerophosphoethanolamine helper lipids. Bioconjug.Chem., 12, 949-963.
230
470.Gaucheron J., Santaella C., Vierling P. (2001) Improved in vitro gene transfer mediated by fluorinated lipoplexes in the presence of a bile salt surfactant. J.Gene Med., 3, 338-344.
471.Gaucheron J., Santaella C., Vierling P. (2001) Highly fluorinated lipospermines for gene transfer: synthesis and evaluation of their in vitro transfection efficiency. Bioconjug.Chem., 12, 114-128.
472.Fabio K., Di Giorgio C., Vierling P. (2005) New perfluorinated polycationic dimerizable detergents for the formulation of monomolecular DNA nanoparticles and their in vitro transfection efficiency. Biochim.Biophys.Acta, 1724, 203-214.
473.Cherstvy A.G. (2007) Electrostatics of DNA complexes with cationic lipid membranes. J.Phys.Chem.B, 111, 7914-7927.
474.Pantazatos D.P., Pantazatos S.P., MacDonald R.C. (2003) Bilayer mixing, fusion, and lysis following the interaction of populations of cationic and anionic phospholipid bilayer vesicles. J.Membr.Biol., 194, 129-139.
475.Kennedy M.T., Pozharski E.V., Rakhmanova V.A., MacDonald R.C. (2000) Factors governing the assembly of cationic phospholipid-DNA complexes. Biophys.J., 78, 1620-1633.
476.Rakhmanova V.A., Pozharski E.V., MacDonald R.C. (2004) Mechanisms of lipoplex formation: dependence of the biological properties of transfection complexes on formulation procedures. J.Membr.Biol., 200, 35-45.
477.Wasan E.K., Harvie P., Edwards K., Karlsson G., Bally M.B. (1999) A multi-step lipid mixing assay to model structural changes in cationic lipoplexes used for in vitro transfection.
Biochim.Biophys.Acta, 1461, 27-46.
478.Clausen-Schaumann H., Gaub H.E. (1999) DNA adsorption to laterally structured charged lipid membranes. Langmuir, 15, 8246-8251.
479.Huebner S., Battersby B.J., Grimm R., Cevc G. (1999) Lipid-DNA complex formation: reorganization and rupture of lipid vesicles in the presence of DNA as observed by cryoelectron microscopy. Biophys.J., 76, 3158-3166.
480.Radler J.O., Koltover I., Salditt T., Safinya C.R. (1997) Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science, 275, 810-814.
481.Ewert K., Slack N.L., Ahmad A., Evans H.M., Lin A.J., Samuel C.E., Safinya C.R. (2004) Cationic lipid-DNA complexes for gene therapy: understanding the relationship between complex structure and gene delivery pathways at the molecular level.
Curr.Med.Chem., 11, 133-149.
482.Lin A.J., Slack N.L., Ahmad A., George C.X., Samuel C.E., Safinya C.R. (2003) Three-dimensional imaging of lipid gene-carriers: membrane charge density controls universal transfection behavior in lamellar cationic liposome-DNA complexes. Biophys.J., 84, 3307-3316.
483.Safinya C.R. (2001) Structures of lipid-DNA complexes: supramolecular assembly and gene delivery. Curr.Opin.Struct.Biol., 11, 440-448.
484.Koltover I., Salditt T., Radler J.O., Safinya C.R. (1998) An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science, 281, 78-
485.Schmutz M., Durand D., Debin A., Palvadeau Y., Etienne A., Thierry A.R. (1999) DNA packing in stable lipid complexes designed for gene transfer imitates DNA compaction in bacteriophage. Proc.Natl.Acad.Sci.U.S.A, 96, 12293-12298.
486.Safinya C.R., Ewert K., Ahmad A., Evans H.M., Raviv U., Needleman D.J., Lin A.J., Slack N.L., George C., Samuel C.E. (2006) Cationic liposome-DNA complexes: from liquid crystal science to gene delivery applications. Philos.Transact.A Math.Phys.Eng Sci., 364, 2573-2596.
487.Battersby B.J., Grimm R., Huebner S., Cevc G. (1998) Evidence for three-dimensional interlayer correlations in cationic lipid-DNA complexes as observed by cryo-electron microscopy. Biochim.Biophys.Acta, 1372, 379-383.
488.Gustafsson J., Arvidson G., Karlsson G., Almgren M. (1995) Complexes between cationic liposomes and DNA visualized by cryo-TEM. Biochim.Biophys.Acta, 1235, 305-312.
489.Barreleiro P.C., May R.P., Lindman B. (2002) Mechanism of formation of DNAcationic vesicle complexes. Faraday Discuss., 122, 191-201.
231
490.Oberle V., Bakowsky U., Zuhorn I.S., Hoekstra D. (2000) Lipoplex formation under equilibrium conditions reveals a three-step mechanism. Biophys.J., 79, 1447-1454.
491.Pozharski E.V., MacDonald R.C. (2007) Single lipoplex study of cationic lipoid-DNA, self-assembled complexes. Mol.Pharm., 4, 962-974.
492.Tarahovsky Y.S., Khusainova R.S., Gorelov A.V., Nicolaeva T.I., Deev A.A., Dawson A.K., Ivanitsky G.R. (1996) DNA initiates polymorphic structural transitions in lecithin. FEBS Lett., 390, 133-136.
493.Sternberg B., Sorgi F.L., Huang L. (1994) New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. FEBS Lett., 356, 361-366.
494.Sternberg B., Hong K., Zheng W., Papahadjopoulos D. (1998) Ultrastructural characterization of cationic liposome-DNA complexes showing enhanced stability in serum and high transfection activity in vivo. Biochim.Biophys.Acta, 1375, 23-35.
495.Ewert K.K., Ahmad A., Evans H.M., Safinya C.R. (2005) Cationic lipid-DNA complexes for non-viral gene therapy: relating supramolecular structures to cellular pathways.
Expert.Opin.Biol.Ther., 5, 33-53.
496.Ewert K., Evans H.M., Ahmad A., Slack N.L., Lin A.J., Martin-Herranz A., Safinya C.R. (2005) Lipoplex structures and their distinct cellular pathways. Adv.Genet., 53, 119-155.
497.Lin A.J., Slack N.L., Ahmad A., Koltover I., George C.X., Samuel C.E., Safinya C.R. (2000) Structure and structure-function studies of lipid/plasmid DNA complexes. J.Drug Target, 8, 13-27.
498.Feitosa E., Barreleiro P.C., Olofsson G. (2000) Phase transition in dioctadecyldimethylammonium bromide and chloride vesicles prepared by different methods.
Chem.Phys.Lipids, 105, 201-213.
499.Barreleiro P.C., Olofsson G., Alexandridis P. (2000) Interaction of DNA with cationic vesicles: a calorimetric study. J.Phys.Chem.B, 104, 7795-7802.
500.Zantl R., Baicu L., Artzner F., Sprenger I., Rapp G., Radler J.O. (1999) Thermotropic phase behavior of cationic lipid-DNA complexes compared to binary lipid mixing. J.Phys.Chem.B, 103, 10300-10310.
501.Lobo B.A., Rogers S.A., Choosakoonkriang S., Smith J.G., Koe G., Middaugh C.R. (2002) Differential scanning calorimetric studies of the thermal stability of plasmid DNA complexed with cationic lipids and polymers. J.Pharm.Sci., 91, 454-466.
502.Tarahovsky Y.S., Rakhmanova V.A., Epand R.M., MacDonald R.C. (2002) High temperature stabilization of DNA in complexes with cationic lipids. Biophys.J., 82, 264-273.
503.Simberg D., Danino D., Talmon Y., Minsky A., Ferrari M.E., Wheeler C.J., Barenholz Y. (2001) Phase behavior, DNA ordering, and size instability of cationic lipoplexes. Relevance to optimal transfection activity. J.Biol.Chem., 276, 47453-47459.
504.Zuhorn I.S., Oberle V., Visser W.H., Engberts J.B., Bakowsky U., Polushkin E., Hoekstra D. (2002) Phase behavior of cationic amphiphiles and their mixtures with helper lipid influences lipoplex shape, DNA translocation, and transfection efficiency. Biophys.J., 83, 2096-2108.
505.Hafez I.M., Cullis P.R. (2001) Roles of lipid polymorphism in intracellular delivery.
Adv.Drug Deliv.Rev., 47, 139-148.
506.Hafez I.M., Maurer N., Cullis P.R. (2001) On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther., 8, 1188-1196.
507.Congiu A., Pozzi D., Esposito C., Castellano C., Mossa G. (2004) Correlation between structure and transfection efficiency: a study of DC-Chol – DOPE/DNA complexes . Colloids Surf.B Biointerfaces., 36, 43-48.
508.Koynova R., MacDonald R.C. (2003) Mixtures of cationic lipid O- ethylphosphatidylcholine with membrane lipids and DNA: phase diagrams. Biophys.J., 85, 2449-2465.
509.Wang L., MacDonald R.C. (2004) New strategy for transfection: mixtures of mediumchain and long-chain cationic lipids synergistically enhance transfection. Gene Ther., 11, 1358-1362.
510.Wang L., MacDonald R.C. (2007) Synergistic effect between components of mixtures of cationic amphipaths in transfection of primary endothelial cells. Mol.Pharm., 4, 615-623.
232
511.Koynova R., Tarahovsky Y.S., Wang L., MacDonald R.C. (2007) Lipoplex formulation of superior efficacy exhibits high surface activity and fusogenicity, and readily releases DNA. Biochim.Biophys.Acta, 1768, 375-386.
512.Tenchov B.G., Wang L., Koynova R., MacDonald R.C. (2008) Modulation of a membrane lipid lamellar-nonlamellar phase transition by cationic lipids: a measure for transfection efficiency. Biochim.Biophys.Acta, 1778, 2405-2412.
513.Koynova R., Wang L., MacDonald R.C. (2008) Cationic phospholipids forming cubic phases: lipoplex structure and transfection efficiency. Mol.Pharm., 5, 739-744.
514.Tarahovsky Y.S., Koynova R., MacDonald R.C. (2004) DNA release from lipoplexes by anionic lipids: correlation with lipid mesomorphism, interfacial curvature, and membrane fusion. Biophys.J., 87, 1054-1064.
515.Mislick K.A., Baldeschwieler J.D. (1996) Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc.Natl.Acad.Sci.U.S.A, 93, 12349-12354.
516.Arnberg N., Kidd A.H., Edlund K., Nilsson J., Pring-Akerblom P., Wadell G. (2002) Adenovirus type 37 binds to cell surface sialic acid through a charge-dependent interaction. Virology, 302, 33-43.
517.Pankov R., Markovska T., Antonov P., Ivanova L., Momchilova A. (2006) The plasma membrane lipid composition affects fusion between cells and model membranes.
Chem.Biol.Interact., 164, 167-173.
518.Pires P., Simoes S., Nir S., Gaspar R., Duzgunes N., Pedroso de Lima M.C. (1999) Interaction of cationic liposomes and their DNA complexes with monocytic leukemia cells.
Biochim.Biophys.Acta, 1418, 71-84.
519.Saito Y., Kawakami S., Yabe Y., Yamashita F., Hashida M. (2006) Intracellular trafficking is the important process that determines the optimal charge ratio on transfection by galactosylated lipoplex in HEPG2 cells. Biol.Pharm.Bull., 29, 1986-1990.
520.Pelisek J., Gaedtke L., DeRouchey J., Walker G.F., Nikol S., Wagner E. (2006) Optimized lipopolyplex formulations for gene transfer to human colon carcinoma cells under in vitro conditions. J.Gene Med., 8, 186-197.
521.Ross P.C., Hui S.W. (1999) Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther., 6, 651-659.
522.Rejman J., Oberle V., Zuhorn I.S., Hoekstra D. (2004) Size-dependent internalization of particles via the pathways of clathrinand caveolae-mediated endocytosis. Biochem.J., 377, 159-169.
523.Kawaura C., Noguchi A., Furuno T., Nakanishi M. (1998) Atomic force microscopy for studying gene transfection mediated by cationic liposomes with a cationic cholesterol derivative. FEBS Lett., 421, 69-72.
524.Nakanishi M., Noguchi A. (2001) Confocal and probe microscopy to study gene transfection mediated by cationic liposomes with a cationic cholesterol derivative. Adv.Drug Deliv.Rev., 52, 197-207.
525.Trubetskoy V.S., Wong S.C., Subbotin V., Budker V.G., Loomis A., Hagstrom J.E., Wolff J.A. (2003) Recharging cationic DNA complexes with highly charged polyanions for in vitro and in vivo gene delivery. Gene Ther., 10, 261-271.
526.Simberg D., Weisman S., Talmon Y., Barenholz Y. (2004) DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Crit Rev.Ther.Drug Carrier Syst., 21, 257-
527.Wrobel I., Collins D. (1995) Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim.Biophys.Acta, 1235, 296-304.
528.Friend D.S., Papahadjopoulos D., Debs R.J. (1996) Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim.Biophys.Acta, 1278, 41-50.
529.Briane D., Lesage D., Cao A., Coudert R., Lievre N., Salzmann J.L., Taillandier E. (2002) Cellular pathway of plasmids vectorized by cholesterol-based cationic liposomes.
J.Histochem.Cytochem., 50, 983-991.
530.Cao A., Briane D., Coudert R., Vassy J., Lievre N., Olsman E., Tamboise E., Salzmann J.L., Rigaut J.P., Taillandier E. (2000) Delivery and pathway in MCF7 cells of DNA vectorized by cationic liposomes derived from cholesterol. Antisense Nucleic Acid Drug Dev., 10, 369-380.
233
531.Tamaddon A.M., Shirazi F.H., Moghimi H.R. (2007) Modeling cytoplasmic release of encapsulated oligonucleotides from cationic liposomes. Int.J.Pharm., 336, 174-182.
532.Thurston G., McLean J.W., Rizen M., Baluk P., Haskell A., Murphy T.J., Hanahan D., McDonald D.M. (1998) Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J.Clin.Invest, 101, 1401-1413.
533.Holmen S.L., Vanbrocklin M.W., Eversole R.R., Stapleton S.R., Ginsberg L.C. (1995) Efficient lipid-mediated transfection of DNA into primary rat hepatocytes. In Vitro Cell Dev.Biol.Anim, 31, 347-351.
534.Colin M., Maurice M., Trugnan G., Kornprobst M., Harbottle R.P., Knight A., Cooper R.G., Miller A.D., Capeau J., Coutelle C., Brahimi-Horn M.C. (2000) Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells. Gene Ther., 7, 139-152.
535.El Ouahabi A., Thiry M., Schiffmann S., Fuks R., Nguyen-Tran H., Ruysschaert J.M., Vandenbranden M. (1999) Intracellular visualization of BrdU-labeled plasmid DNA/cationic liposome complexes. J.Histochem.Cytochem., 47, 1159-1166.
536.Hasegawa S., Hirashima N., Nakanishi M. (2001) Microtubule involvement in the intracellular dynamics for gene transfection mediated by cationic liposomes. Gene Ther., 8, 1669-1673.
537.Ondrej V., Lukasova E., Falk M., Kozubek S. (2007) The role of actin and microtubule networks in plasmid DNA intracellular trafficking. Acta Biochim.Pol., 54, 657-663.
538.Rejman J., Bragonzi A., Conese M. (2005) Role of clathrinand caveolae-mediated endocytosis in gene transfer mediated by lipoand polyplexes. Mol.Ther., 12, 468-474.
539.Rejman J., Conese M., Hoekstra D. (2006) Gene transfer by means of lipoand polyplexes: role of clathrin and caveolae-mediated endocytosis. J.Liposome Res., 16, 237-
540.Huth U., Wieschollek A., Garini Y., Schubert R., Peschka-Suss R. (2004) Fourier transformed spectral bio-imaging for studying the intracellular fate of liposomes. Cytometry A, 57, 10-21.
541.Sakurai F., Inoue R., Nishino Y., Okuda A., Matsumoto O., Taga T., Yamashita F., Takakura Y., Hashida M. (2000) Effect of DNA/liposome mixing ratio on the physicochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression. J.Control Release, 66, 255-269.
542.Zuhorn I.S., Kalicharan R., Hoekstra D. (2002) Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis. J.Biol.Chem., 277, 18021-18028.
543.Watson P., Jones A.T., Stephens D.J. (2005) Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. Adv.Drug Deliv.Rev., 57, 43-61.
544.Wang L., MacDonald R.C. (2004) Effects of microtubule-depolymerizing agents on the transfection of cultured vascular smooth muscle cells: enhanced expression with free drug and especially with drug-gene lipoplexes. Mol.Ther., 9, 729-737.
545.Чеботарева Н.А. (2007) Влияние молекулярного краудинга на ферменты гликогенолиза. Успехи Биол.Химиии, 47, 233-258.
546.Ellis R.J. (2007) Protein misassembly: macromolecular crowding and molecular chaperones. Adv.Exp.Med.Biol., 594, 1-13.
547.Lukacs G.L., Haggie P., Seksek O., Lechardeur D., Freedman N., Verkman A.S. (2000) Size-dependent DNA mobility in cytoplasm and nucleus. J.Biol.Chem., 275, 16251629.
548.Hirashima N., Minatani K., Hattori Y., Ohwada T., Nakanishi M. (2007) Anchoring cationic amphiphiles for nucleotide delivery: significance of DNA release from cationic liposomes for transfection. Biol.Pharm.Bull., 30, 1117-1122.
549.Zhou X., Huang L. (1994) DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim.Biophys.Acta, 1189, 195-203.
550.Cheng J., Zeidan R., Mishra S., Liu A., Pun S.H., Kulkarni R.P., Jensen G.S., Bellocq N.C., Davis M.E. (2006) Structure-function correlation of chloroquine and analogues as transgene expression enhancers in nonviral gene delivery. J.Med.Chem., 49, 6522-6531.
234
551.Ciftci K., Levy R.J. (2001) Enhanced plasmid DNA transfection with lysosomotropic agents in cultured fibroblasts. Int.J.Pharm., 218, 81-92.
552.Legendre J.Y., Szoka F.C., Jr. (1992) Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes. Pharm.Res., 9, 1235-1242.
553.Akinc A., Thomas M., Klibanov A.M., Langer R. (2005) Exploring polyethyleniminemediated DNA transfection and the proton sponge hypothesis. J.Gene Med., 7, 657-663.
554.Pan H., Zheng Q., Guo X., Liu Y., Li C., Song Y. (2006) A RGD-containing oligopeptide (K)16GRGDSPC: a novel vector for integrin-mediated targeted gene delivery.
J.Huazhong.Univ Sci.Technolog.Med.Sci., 26, 513-516.
555.Hafez I.M., Ansell S., Cullis P.R. (2000) Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids. Biophys.J., 79, 1438-1446.
556.Hafez I.M., Cullis P.R. (2004) Tunable pH-sensitive liposomes. Methods Enzymol., 387, 113-134.
557.Bhattacharya S., Mandal S.S. (1998) Evidence of interlipidic ion-pairing in anioninduced DNA release from cationic amphiphile-DNA complexes. Mechanistic implications in transfection. Biochemistry, 37, 7764-7777.
558.Xu Y., Szoka F.C., Jr. (1996) Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry, 35, 5616-5623.
559.Kinnunen P.K., Rytomaa M., Koiv A., Lehtonen J., Mustonen P., Aro A. (1993) Sphingosine-mediated membrane association of DNA and its reversal by phosphatidic acid.
Chem.Phys.Lipids, 66, 75-85.
560.Lewis R.N., McElhaney R.N. (2000) Surface charge markedly attenuates the nonlamellar phase-forming propensities of lipid bilayer membranes: calorimetric and (31)P- nuclear magnetic resonance studies of mixtures of cationic, anionic, and zwitterionic lipids. Biophys.J., 79, 1455-1464.
561.Cevc G., Richardsen H. (1999) Lipid vesicles and membrane fusion. Adv.Drug Deliv.Rev., 38, 207-232.
562.Marrink S.J., Tieleman D.P. (2002) Molecular dynamics simulation of spontaneous membrane fusion during a cubic-hexagonal phase transition. Biophys.J., 83, 2386-2392.
563.Marrink S.J., Mark A.E. (2004) Molecular view of hexagonal phase formation in phospholipid membranes. Biophys.J., 87, 3894-3900.
564.Siegel D.P. (1999) The modified stalk mechanism of lamellar/inverted phase transitions and its implications for membrane fusion. Biophys.J., 76, 291-313.
565.Harvie P., Wong F.M., Bally M.B. (1998) Characterization of lipid DNA interactions. I. Destabilization of bound lipids and DNA dissociation. Biophys.J., 75, 1040-1051.
566.Scherman D., Bessodes M., Cameron B., Herscovici J., Hofland H., Pitard B., Soubrier F., Wils P., Crouzet J. (1998) Application of lipids and plasmid design for gene delivery to mammalian cells. Curr.Opin.Biotechnol., 9, 480-485.
567.Inoh Y., Kitamoto D., Hirashima N., Nakanishi M. (2004) Biosurfactant MEL-A dramatically increases gene transfection via membrane fusion. J.Control Release, 94, 423-
568.Almofti M.R., Harashima H., Shinohara Y., Almofti A., Baba Y., Kiwada H. (2003) Cationic liposome-mediated gene delivery: biophysical study and mechanism of internalization. Arch.Biochem.Biophys., 410, 246-253.
569.Stebelska K., Wyrozumska P., Gubernator J., Sikorski A.F. (2007) Highly fusogenic cationic liposomes transiently permeabilize the plasma membrane of HeLa cells. Cell Mol.Biol.Lett., 12, 39-50.
570.Farago O., Ewert K., Ahmad A., Evans H.M., Gronbech-Jensen N., Safinya C.R. (2008) Transitions between distinct compaction regimes in complexes of multivalent cationic lipids and DNA. Biophys.J., 95, 836-846.
571.Ahmad A., Evans H.M., Ewert K., George C.X., Samuel C.E., Safinya C.R. (2005) New multivalent cationic lipids reveal bell curve for transfection efficiency versus membrane charge density: lipid-DNA complexes for gene delivery. J.Gene Med., 7, 739-748.
572.Noguchi A., Furuno T., Kawaura C., Nakanishi M. (1998) Membrane fusion plays an important role in gene transfection mediated by cationic liposomes. FEBS Lett., 433, 169-173.
235
573.Altman P.L., Katz D.D. (1976) "Cell biology" Bethesda, Maryland, Fed.Am.Soc.Exp.Biol.
574.Lesage D., Cao A., Briane D., Lievre N., Coudert R., Raphael M., Salzmann J., Taillandier E. (2002) Evaluation and optimization of DNA delivery into gliosarcoma 9L cells by a cholesterol-based cationic liposome. Biochim.Biophys.Acta, 1564, 393-402.
575.Brunner S., Furtbauer E., Sauer T., Kursa M., Wagner E. (2002) Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol.Ther., 5, 80-86.
576.Brunner S., Sauer T., Carotta S., Cotten M., Saltik M., Wagner E. (2000) Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther., 7, 401-407.
577.Tseng W.C., Haselton F.R., Giorgio T.D. (1999) Mitosis enhances transgene expression of plasmid delivered by cationic liposomes. Biochim.Biophys.Acta, 1445, 53-64.
578.Mortimer I., Tam P., MacLachlan I., Graham R.W., Saravolac E.G., Joshi P.B. (1999) Cationic lipid-mediated transfection of cells in culture requires mitotic activity. Gene Ther., 6, 403-411.
579.Kamiya H., Fujimura Y., Matsuoka I., Harashima H. (2002) Visualization of intracellular trafficking of exogenous DNA delivered by cationic liposomes. Biochem.Biophys.Res.Commun., 298, 591-597.
580.Bergen J.M., Pun S.H. (2008) Analysis of the intracellular barriers encountered by nonviral gene carriers in a model of spatially controlled delivery to neurons. J.Gene Med., 10, 187-197.
581.Dowty M.E., Williams P., Zhang G., Hagstrom J.E., Wolff J.A. (1995) Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. Proc.Natl.Acad.Sci.U.S.A, 92, 45724576.
582.Pollard H., Remy J.S., Loussouarn G., Demolombe S., Behr J.P., Escande D. (1998) Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J.Biol.Chem., 273, 7507-7511.
583.Escriou V., Carriere M., Bussone F., Wils P., Scherman D. (2001) Critical assessment of the nuclear import of plasmid during cationic lipid-mediated gene transfer. J.Gene Med., 3, 179-187.
584.Lechardeur D., Sohn K.J., Haardt M., Joshi P.B., Monck M., Graham R.W., Beatty B., Squire J., O'Brodovich H., Lukacs G.L. (1999) Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther., 6, 482-497.
585.Rolland A. (2006) Nuclear gene delivery: the Trojan horse approach. Expert.Opin.Drug Deliv., 3, 1-10.
586.Doye V., Hurt E. (1997) From nucleoporins to nuclear pore complexes.
Curr.Opin.Cell Biol., 9, 401-411.
587.Wente S.R. (2000) Gatekeepers of the nucleus. Science, 288, 1374-1377.
588.Stoffler D., Feja B., Fahrenkrog B., Walz J., Typke D., Aebi U. (2003) Cryo-electron tomography provides novel insights into nuclear pore architecture: implications for nucleocytoplasmic transport. J.Mol.Biol., 328, 119-130.
589.Pante N., Kann M. (2002) Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. Mol.Biol.Cell, 13, 425-434.
590.Ludtke J.J., Zhang G., Sebestyen M.G., Wolff J.A. (1999) A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. J.Cell Sci., 112, 20332041.
591.Hartmann L., Hafele S., Peschka-Suss R., Antonietti M., Borner H.G. (2008) Tailormade poly(amidoamine)s for controlled complexation and condensation of DNA. Chemistry., 14, 2025-2033.
592.Lambert O., Letellier L., Gelbart W.M., Rigaud J.L. (2000) DNA delivery by phage as a strategy for encapsulating toroidal condensates of arbitrary size into liposomes.
Proc.Natl.Acad.Sci.U.S.A, 97, 7248-7253.
593.Zuber G., Zammut-Italiano L., Dauty E., Behr J.P. (2003) Targeted gene delivery to cancer cells: directed assembly of nanometric DNA particles coated with folic acid.
Angew.Chem.Int.Ed Engl., 42, 2666-2669.
236
594.Chauhan A., Tikoo A., Kapur A.K., Singh M. (2007) The taming of the cell penetrating domain of the HIV Tat: myths and realities. J.Control Release, 117, 148-162.
595.Kim K., Han J.S., Kim H.A., Lee M. (2008) Expression, purification and characterization of TAT-high mobility group box-1A peptide as a carrier of nucleic acids. Biotechnol.Lett., 30, 1331-1337.
596.Torchilin V.P. (2008) Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers.
597.Chan C.K., Jans D.A. (2002) Using nuclear targeting signals to enhance non-viral gene transfer. Immunol.Cell Biol., 80, 119-130.
598.Hebert E. (2003) Improvement of exogenous DNA nuclear importation by nuclear localization signal-bearing vectors: a promising way for non-viral gene therapy? Biol.Cell, 95, 59-68.
599.Liu G., Li D., Pasumarthy M.K., Kowalczyk T.H., Gedeon C.R., Hyatt S.L., Payne J.M., Miller T.J., Brunovskis P., Fink T.L., Muhammad O., Moen R.C., Hanson R.W., Cooper M.J. (2003) Nanoparticles of compacted DNA transfect postmitotic cells. J.Biol.Chem., 278, 32578-32586.
600.Belting M., Sandgren S., Wittrup A. (2005) Nuclear delivery of macromolecules: barriers and carriers. Adv.Drug Deliv.Rev., 57, 505-527.
601.Salman H., Abu-Arish A., Oliel S., Loyter A., Klafter J., Granek R., Elbaum M. (2005) Nuclear localization signal peptides induce molecular delivery along microtubules. Biophys.J., 89, 2134-2145.
602.Gump J.M., Dowdy S.F. (2007) TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol.Med., 13, 443-448.
603.Lo S.L., Wang S. (2008) An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials, 29, 2408-2414.
604.Meyer M., Zintchenko A., Ogris M., Wagner E. (2007) A dimethylmaleic acid- melittin-polylysine conjugate with reduced toxicity, pH-triggered endosomolytic activity and enhanced gene transfer potential. J.Gene Med., 9, 797-805.
605.Boeckle S., Wagner E., Ogris M. (2005) C- versus N-terminally linked melittinpolyethylenimine conjugates: the site of linkage strongly influences activity of DNA polyplexes. J.Gene Med., 7, 1335-1347.
606.Prongidi-Fix L., Sugawara M., Bertani P., Raya J., Leborgne C., Kichler A., Bechinger B. (2007) Self-promoted cellular uptake of peptide/DNA transfection complexes. Biochemistry, 46, 11253-11262.
607.Almeida J.D., Edwards D.C., Brand C.M., Heath T.D. (1975) Formation of virosomes from influenza subunits and liposomes. Lancet, 2, 899-901.
608.Helenius A., Fries E., Kartenbeck J. (1977) Reconstitution of Semliki forest virus membrane. J.Cell Biol., 75, 866-880.
609.Corver J., Moesby L., Erukulla R.K., Reddy K.C., Bittman R., Wilschut J. (1995) Sphingolipid-dependent fusion of Semliki Forest virus with cholesterol-containing liposomes requires both the 3-hydroxyl group and the double bond of the sphingolipid backbone. J.Virol., 69, 3220-3223.
610.Smit J.M., Waarts B.L., Kimata K., Klimstra W.B., Bittman R., Wilschut J. (2002) Adaptation of alphaviruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin. J.Virol., 76, 10128-10137.
611.Wilschut J., Corver J., Nieva J.L., Bron R., Moesby L., Reddy K.C., Bittman R. (1995) Fusion of Semliki Forest virus with cholesterol-containing liposomes at low pH: a specific requirement for sphingolipids. Mol.Membr.Biol., 12, 143-149.
612.Bagai S., Sarkar D.P. (1993) Reconstituted Sendai virus envelopes as biological carriers: dual role of F protein in binding and fusion with liver cells. Biochim.Biophys.Acta, 1152, 15-25.
613.Bagai S., Sarkar D.P. (1994) Effect of substitution of hemagglutinin-neuraminidase with influenza hemagglutinin on Sendai virus F protein mediated membrane fusion. FEBS Lett., 353, 332-336.
614.Kim H.S., Park Y.S. (2002) Gene transfection by quantitatively reconstituted Sendai envelope proteins into liposomes. Cancer Gene Ther., 9, 173-177.
237
615.Kim H.S., Park Y.S. (2002) Effect of lipid compositions on gene transfer into 293 cells using Sendai F/HN-virosomes. J.Biochem.Mol.Biol., 35, 459-464.
616.Ponimaskin E., Bareesel K.K., Markgraf K., Reszka R., Lehmann K., Gelderblom H.R., Gawaz M., Schmidt M.F. (2000) Sendai virosomes revisited: reconstitution with exogenous lipids leads to potent vehicles for gene transfer. Virology, 269, 391-403.
617.Loh D., Ross A.H., Hale A.H., Baltimore D., Eisen H.N. (1979) Synthetic phospholipid vesicles containing a purified viral antigen and cell membrane proteins stimulate the development of cytotoxic T lymphocytes. J.Exp.Med., 150, 1067-1074.
618.Shoji J., Tanihara Y., Uchiyama T., Kawai A. (2004) Preparation of virosomes coated with the vesicular stomatitis virus glycoprotein as efficient gene transfer vehicles for animal cells. Microbiol.Immunol., 48, 163-174.
619.Hug P., Sleight R.G. (1994) Fusogenic virosomes prepared by partitioning of vesicular stomatitis virus G protein into preformed vesicles. J.Biol.Chem., 269, 4050-4056.
620.Abe A., Miyanohara A., Friedmann T. (1998) Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein. J.Virol., 72, 6159-6163.
621.Orellana A., Mottershead D., van d.L., I, Keinanen K., Oker-Blom C. (1999) Mimicking rubella virus particles by using recombinant envelope glycoproteins and liposomes. J.Biotechnol., 75, 209-219.
622.Grimaldi S., Giuliani A., Giuliani A., Ferroni L., Lisi A., Santoro N., Pozzi D. (1995) Engineered liposomes and virosomes for delivery of macromolecules. Res.Virol., 146, 289-
623.Saeki Y., Wataya-Kaneda M., Tanaka K., Kaneda Y. (1998) Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes. Gene Ther., 5, 1031-1037.
624.Schneider J., Falk H., Hunsmann G. (1983) Virosomes constructed from lipid and purified Friend leukaemia virus glycoprotein. J.Gen.Virol., 64 Pt 3, 559-565.
625.Cornet B., Vandenbranden M., Cogniaux J., Giurgea L., Dekegel D., Ruysschaert J.M. (1990) Virosomes reconstituted from human immunodeficiency virus proteins and lipids.
Biochem.Biophys.Res.Commun., 167, 222-231.
626.Tu Y., Kim J.S. (2008) A fusogenic segment of glycoprotein H from herpes simplex virus enhances transfection efficiency of cationic liposomes. J.Gene Med., 10, 646-654.
627.Mizuno M., Ryuke Y., Yoshida J. (2002) Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models. Cancer Gene Ther., 9, 825-829.
628.Hasegawa H., Shimada M., Yonemitsu Y., Utsunomiya T., Gion T., Kaneda Y., Sugimachi K. (2001) Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase. Cancer Gene Ther., 8, 252-258.
629.Lawman M.J., Naylor P.T., Huang L., Courtney R.J., Rouse B.T. (1981) Cell-mediated immunity to herpes simplex virus: induction of cytotoxic T lymphocyte responses by viral antigens incorporated into liposomes. J.Immunol., 126, 304-308.
630.Kapczynski D.R., Tumpey T.M. (2003) Development of a virosome vaccine for Newcastle disease virus. Avian Dis., 47, 578-587.
631.Huckriede A., Bungener L., Daemen T., Wilschut J. (2003) Influenza virosomes in vaccine development. Methods Enzymol., 373, 74-91.
632.Daemen T., de Mare A., Bungener L., de Jonge J., Huckriede A., Wilschut J. (2005) Virosomes for antigen and DNA delivery. Adv.Drug Deliv.Rev., 57, 451-463.
633.Huckriede A., Bungener L., Stegmann T., Daemen T., Medema J., Palache A.M., Wilschut J. (2005) The virosome concept for influenza vaccines. Vaccine, 23 Suppl 1, S26S38.
634.Wilschut J. (2009) Influenza vaccines: the virosome concept. Immunol.Lett., 122, 118-
635.Stegmann T., Morselt H.W., Booy F.P., van Breemen J.F., Scherphof G., Wilschut J. (1987) Functional reconstitution of influenza virus envelopes. EMBO J., 6, 2651-2659.
238
636.Arkema A., Huckriede A., Schoen P., Wilschut J., Daemen T. (2000) Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes. Vaccine, 18, 1327-1333.
637.Bungener L., Huckriede A., de Mare A., Vries-Idema J., Wilschut J., Daemen T. (2005) Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity. Vaccine, 23, 1232-1241.
638.Bungener L., Serre K., Bijl L., Leserman L., Wilschut J., Daemen T., Machy P. (2002) Virosome-mediated delivery of protein antigens to dendritic cells. Vaccine, 20, 2287-2295.
639.de Jonge J., Holtrop M., Wilschut J., Huckriede A. (2006) Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs. Gene Ther., 13, 400-411.
640.Schoen P., Chonn A., Cullis P.R., Wilschut J., Scherrer P. (1999) Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles. Gene Ther., 6, 823-832.
641.Correale P., Cusi M.G., Sabatino M., Micheli L., Pozzessere D., Nencini C., Valensin P.E., Petrioli R., Giorgi G., Zurbriggen R., Gluck R., Francini G. (2001) Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes. Eur.J.Cancer, 37, 2097-2103.
642.Gluck R., Mischler R., Brantschen S., Just M., Althaus B., Cryz S.J., Jr. (1992) Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A. J.Clin.Invest, 90, 2491-2495.
643.Moser C., Amacker M., Kammer A.R., Rasi S., Westerfeld N., Zurbriggen R. (2007) Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations. Expert.Rev.Vaccines., 6, 711-721.
644.Zurbriggen R., Gluck R. (1999) Immunogenicity of IRIV - versus alum-adjuvanted diftheria and tetanus toxoid vaccines in influenza primed mice. Vaccine, 17, 1301-1305.
645.Zurbriggen R., Novak-Hofer I., Seelig A., Gluck R. (2000) IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization. Prog.Lipid Res., 39, 3-18.
646.Cusi M.G., Gluck R. (2000) Potential of DNA vaccines delivered by influenza virosomes. Vaccine, 18, 1435.
647.Cusi M.G., Terrosi C., Savellini G.G., Di Genova G., Zurbriggen R., Correale P. (2004) Efficient delivery of DNA to dendritic cells mediated by influenza virosomes. Vaccine, 22, 735-739.
648.Tuffin G., Waelti E., Huwyler J., Hammer C., Marti H.P. (2005) Immunoliposome targeting to mesangial cells: a promising strategy for specific drug delivery to the kidney.
J.Am.Soc.Nephrol., 16, 3295-3305.
649.Waelti E., Wegmann N., Schwaninger R., Wetterwald A., Wingenfeld C., RothenRutishauser B., Gimmi C.D. (2002) Targeting her-2/neu with antirat Neu virosomes for cancer therapy. Cancer Res., 62, 437-444.
650.Adamina M., Guller U., Bracci L., Heberer M., Spagnoli G.C., Schumacher R. (2006) Clinical applications of virosomes in cancer immunotherapy. Expert.Opin.Biol.Ther., 6, 11131121.
651.Cusi M.G., Zurbriggen R., Correale P., Valassina M., Terrosi C., Pergola L., Valensin P.E., Gluck R. (2002) Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity. Vaccine, 20, 34363442.
652.Schwaninger R., Waelti E., Zajac P., Wetterwald A., Mueller D., Gimmi C.D. (2004) Virosomes as new carrier system for cancer vaccines. Cancer Immunol.Immunother., 53, 1005-1017.
653.Liu X., Siegrist S., Amacker M., Zurbriggen R., Pluschke G., Seeberger P.H. (2006) Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidate. ACS Chem.Biol., 1, 161-164.
654.Mueller M.S., Renard A., Boato F., Vogel D., Naegeli M., Zurbriggen R., Robinson J.A., Pluschke G. (2003) Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1. Infect.Immun., 71, 4749-4758.